Compare KORE & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KORE | ZTEK |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 78.2M |
| IPO Year | N/A | N/A |
| Metric | KORE | ZTEK |
|---|---|---|
| Price | $5.07 | $0.67 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 44.8K | ★ 70.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.26 | N/A |
| Revenue Next Year | $7.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $0.60 |
| 52 Week High | $5.29 | $1.84 |
| Indicator | KORE | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 38.88 |
| Support Level | $4.76 | $0.62 |
| Resistance Level | $5.13 | $0.69 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 43.64 | 17.10 |
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.